Diagnostic performance of an immunoassay for simultaneous detection of HCV core antigen and antibodies among haemodialysis patients

Brazilian Journal of Microbiology

Volumn 42, Issue 1, 2011, Pages 303-309

  El Emshaty, Wafaa M ^a   Raafat, Douaa ^a   Elghannam, Doaa M ^a   Saudy, Niveen ^a   Eltoraby, Ehab E ^a   Metwalli, Abd Elhameed A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Egypt; Haemodialysis; HCV; HCV core antigen; Immunoassay

Indexed keywords

HEPATITIS C VIRUS;

EID: 79551528015     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822011000100039     Document Type: Article

References (34)

1. Alados-Arboledas, J.C.; Calbo-Torrecillas, L.; López-Prieto, M.D.; de Francisco-Ramírez, J.L.; de Miguel-Sastre, C. (2007) Clinical assessment of Monolisa HCV Ag-Ab ULTRA (Bio-Rad) in a general hospital. Enferm Infecc Microbiol Clin. 25(3):172-176.
2. Alavian, S.M. (2009). A shield against a monster: Hepatitis C in hemodialysis patients. World J Gastroenterol. 14; 15(6):641-646.
3. Alzahrani, A.J. (2008). Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay. J Med Virol. 80(4):603-606
4. Aoyagi, K.; Ohue, C.; Iida, K.; Kimura, T.; Tanaka, E.; Kiyosawa, K.; Yagi, S. (1999). Development of a simple and highly sensitive enzyme immunoassay for HCV core antigen. J. Clin. Microbiol., 37, 1802-1808.
5. Barrera, J.M.; Francis, B.; Ercilla, G.; Nelles, M.; Achord, D.; Darner, J.; Lee, S.R. (1995). Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang., 68, 15-18.
6. Bezerra, C.S.; Lima, M.C.; Vilar, J.L.; Moreira, J.L.B.; Frota, C.C. (2007). Viral hapatitis C in a leading Brazilian hospital: epidemiological factors and genotyping. Braz. J. Microbiol., 38 (4),656-666
7. Busch, M. (2001) Closing the windows on viral transmission by blood transfusion. In: Stramer, S.L., ed. by Bethesda, American Association of Blood Banks, pp. 33-54.
8. Busch, M.P.; Tobler, L.H.; Gerlich, W.H.; Schaefer, S.; Giachetti, C.; Smith, R. (2003). Very low level viremia in HCV infectious unit missed by NAT. Transfusion,43, 1173-1174.
9. Centers for Disease Control and Prevention (CDC) (2001). Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR, 50(No. RR-5): 1-41.
10. Courouce, A.M.; Pillonel, J. (1996). Transfusion-transmitted viral infections. Retrovirus and Viral Hepatitis Working Groups of the French Society of Blood Transfusion. N. Engl. J. Med., 335, 1609-1610.
11. Eassa, S.; Eissa, M.; Sharaf, S.M.; Ibrahim, M.H.; Hassanein, O.M. (2007). Prevalence of hepatitis C virus infection and evaluation of a health education program in el-ghar village in zagazig, Egypt. J. Egypt. Public Health Assoc., 82, 5-6,:379-404.
12. Fabrizi, F.; de Vecchi, A.F.; Como, G.; Lunghi, G.; Martin, P. (2005). De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay. Aliment. Pharmacol. Ther. Apr 1, 21(7), 861-869.
13. Fabrizi, F.; Poordad, F.F.; Martin, P. (2002). Hepatitis C infection and the patient with end-stage renal disease. Hepatology, 36, 3-10.
14. Gallarda, J.L.; Dragon, E. (2000). Blood screening by nucleic acid amplification technology: current issues, future challenge. Mol. Diagn. 5, 11-22.
15. Gonzaga, R.M.S.; Rodart, I.F.; Reis, M.G.N.; Cícero, E.R.; Silva, D.W. (2008). Distribution of Hepatitis C virus (HCV) genotypes in seropositive patients in the state of Alagoas, Brazil. Braz. J. Microbiol., 39 (4), 644-647.
16. Hmaïed, F.; Ben Mamou, M.; Arrouji, Z.; Slim, A.; Ben Redjeb, S. (2007). Use of combined detection of hepatitis C virus core antigen and antibodies to reduce the serological window-phase. Pathol. Biol. (Paris). Mar, 55(2), 121-126.
17. Jain, P.; Nijhawan, S. (2008). Occult hepatitis C virus infection is more common than hepatitis B infection in maintenance hemodialysis patients. World J. Gastroenterol. Apr 14(14), 2288-2289.
18. Laperche, S.; Bouchardeau, F.; Maniez, M.; Béolet, M.; Elghouzzi, M.H.; Lefrère, J.J. (2004). Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load. Vox Sang. 86 (3), 198.
19. Laperche, S.; Elghouzzi, M.H.; Morel, P.; Asso-Bonnet, M.; Le Marrec, N.; Girault, A.; Servant-Delmas, A.; Bouchardeau, F.; Deschaseaux, M.; Piquet, Y. (2005). Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing? Transfusion, Dec., 45(12), 1965-1972.
20. Laperche, S.; Le Marrec, N.; Girault, A.; Bouchardeau, F.; Servant-Delmas, A.; Maniez-Montreuil, M.; Gallian, P.; Levayer, T.; Morel, P.; Simon, N. (2005). Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J. Clin. Microbiol. Aug., 43(8), 3877-3883.
21. Leone, N.; Rizzetto, M. (2005); Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol. Dietol. 51(1), 31-46.
22. Marina, B.; Teresa, L. (2006). Hepatitis C Transmission In Feldman: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 8th ed., Elsevier, pp. 1686.
23. Medhi, S.; Potukuchi, S.K.; Polipalli, S.K.; Swargiary, S.S.; Deka, P.; Chaudhary, A.; Begum, N.; Hussain, Z.; Ahlawat, R.S.; Kar, P. (2008). Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients. Clin. Biochem. 41(7-8), 447-452.
24. Nübling, C.M.; Unger, G.; Chudy, M.; Raia, S.; Löwer, J. (2002). Sensitivity of HCV core antigen and HCV RNA in early infection phase. Transfusion 42, 1037-1045.
25. Operskalski, E.A.; Mosley, J.W.; Tobler, L.H.; Fiebig, E.W.; Nowicki, M.J.; Mimms, L.T.; Gallarda, J.; Phelps, B.H.; Busch, M.P. (2003). HCV viral load in anti-HCV-reactive donors and infectivity for their recipients. Transfusion 43, 1433-1441.
26. Pawlotsky, J.M. (1999). Diagnostic tests for hepatitis C. J. Hepatol. 31(Suppl. 1), 71-79.
27. Ré, V.; Gallego, S.; Treviño, E.; Barbás, G.; Domínguez, C.; Elbarcha, O.; Bepre, H.; Contigiani, M. (2005). Evaluation of five screening tests licensed in Argentina for detection of hepatitis C virus antibodies. Mem. Inst. Oswaldo. Cruz. 100, 303-307.
28. Schneeberger, P.M.; Toonen, N.; Keur, I.; van Hamersvelt, H.W. (1998). Infection control of hepatitis C in Dutch dialysis centres. Nephrol. Dial. Transplant. Dec, 13(12), 3037-3040
29. Shah, D.O.; Chang, C.D.; Jiang, L.X.; Cheng, K.Y.; Muerhoff, A.S.; Gutierrez, R.A.; Leary, T.P.; Desai, S.M.; Batac-Herman, I.V.; Salbilla, V.A.; Haller, A.S.; Stewart, J.L.; Dawson, G.J. (2003). Combination HCV core antigen and antibody assay on a fully automated chemiluminescence analyzer. Transfusion. 43(8), 1067-1074.
30. Thongsawat, S.; Maneekarn, N.; Kuniholm, M.H.; Pantip, C.; Thungsuputi, A.; Lumlertkul, D.; Bannachak, D.; Nelson, K.E. (2008). Occult hepatitis C virus infection during an outbreak in a hem Thailand. J. Med. Virol. 80(5), 808-815.
31. Tokars, J.I.; Finelli, L.; Alter, M.J.; Arduino, M.J. (2004). National surveillance of dialysis-associated diseases in the United States. Semin. Dial. 17, 310-319.
32. Urdea, M.S. (1993). Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV, and HIV. Clin. Chem. 39, 725-726.
33. Xie, L.; Wu, X.D.; Huang, D.Z.; Chen, H.L.; He, L.X.; Wang, J.; Han, D.K. (2007). Clinical application and analysis of hepatitis C virus NS3 antigen detection by ELISA in human serum. Chin. Med. J. (Engl). 120(4), 294-299.
34. Yakaryilmaz, F.; Gurbuz, O.A.; Guliter, S.; Mert, A.; Songur, Y.; Karakan, T.; Keles, H. (2006). Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren. Fail. 28(8), 729-735.